Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks

Abstract

We demonstrate that our approach not only automates an important diagnostic process for GEA patients but also paves the way for the discovery of new morphological features that were previously unknown for GEA pathology.